1 phasic dopamine uptake inhibition similar to meperidine.

2 isk ratio: 1.6, numbers needed to treat: 4), meperidine (16; 2.2, 2), tramadol (8; 2.2, 2), nefopam (

3 ceived intravenous premedication with either meperidine 2 mg/kg and midazolam 0.1 mg/kg (MM) or atrop

4 325 g), and a decrease in the medical use of meperidine (35%; 5.2 to 3.4 million g).

5               Reports of abuse decreased for meperidine (39%; 1335 to 806), oxycodone (29%; 4526 to 3

6                 A series of aryl-substituted meperidine analogues was synthesized, and the binding af

7 tified that were more potent at the DAT than meperidine and that exhibited well-defined biphasic dopa

8        Nonsteroidal anti-inflammatory drugs, meperidine, and morphine are contraindicated in the pres

9 ed affinity for the DAT and SERT relative to meperidine but exhibited low binding affinity for the NE

10 e, l-alpha-acetylmethadone (LAAM), morphine, meperidine, DADL, beta-endorphin(1-31), enkephalins, and

11                                              Meperidine-especially in combination with buspirone-is e

12 oxycodone, propoxyphene, tramadol, morphine, meperidine, fentanyl, or hydroxycodone, either alone or

13 g is inhibited by rotenone (IC50 = 8-20 nM), meperidine (IC50 = 34-57 microM), amobarbitol (IC50 = 37

14 ity of chest pain and required more frequent meperidine injections.

15 nidine pre-treatment on intravenous diazepam/meperidine sedation using the bi-spectral index (BIS) in

16                                              Meperidine should be avoided whenever possible.

17                                   Clonidine, meperidine, tramadol, nefopam, and ketamine were the mos

18 kin warming, oral buspirone, and intravenous meperidine were used to reduce the shivering threshold.